Abbott Laboratories (NYSE: ABT ) ‘ first-quarter earnings were boosted by its nutritional product lines, which include baby formula Similac, adult drink Ensure, and Glucerna bars. In January 2013, the company decided to move away from branded pharmaceuticals, ...
[Published InsiderMonkey.com - May 03 2013]